Therapeutic advances in respiratory disease · 2026
Rigid bronchoscopy using high-flow oxygenation and deep sedation: A feasibility, safety, and patient-reported tolerability survey.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Park Chul, Chae Ganghee, Kim Jin Hyoung, Ra Seung Won, Seo Kwang Won, Jegal Yangjin, Lee Kwan Soo, Jang Munkwon, Son Hee Won, Seol Hee Yun, Lee Taehoon
Аннотация
BackgroundRigid bronchoscopy (RB) is conventionally performed under general anesthesia with jet or mechanical ventilation in an operating room and requires anesthesiologist support. Deep sedation with high-flow oxygenation (HFO), without anesthesiologist or mechanical ventilation, has recently been used for RB at our hospital.ObjectivesWe evaluated the feasibility, safety, and patient-reported tolerability of RB performed under deep sedation with HFO, without general anesthesia or neuromuscular blockade.DesignRetrospective, single-center cohort study.MethodsWe reviewed our institutional registry to identify all consecutive patients who underwent therapeutic RB under deep sedation with HFO. Sedation depth was targeted to a Modified Observer's Assessment of Alertness/Sedation score of 2 or less. Vital signs, end-tidal carbon dioxide, and oxygen saturation were continuously monitored. A patient-reported tolerability survey was administered on the procedure day and 1 week later. The primary endpoint was procedural success; secondary endpoints included intra- and post-procedural complications and patient-reported tolerability.ResultsSixty-eight cases (66 patients) were analyzed between August 2023 and June 2025, including patients with ASA class III or higher (38.2%), a baseline oxygen requirement (80.9%), and urgent or emergent indications (41.2%), reflecting an unselected, all-comers cohort. Procedural success was achieved in 67 cases (98.5%), with a mean procedure time of 45.1 minutes. Complications included hypoxia (13.2%), arrhythmia (7.4%), bleeding (5.9%), and hypotension (1.5%), with no 72-hour procedure-related complications or in-hospital mortality. Sore throat and voice change occurred in 25 (36.8%) and seven (10.3%) cases, respectively, all resolving within a week. Three cases (4.4%) experienced distress during the procedure, and 94.1% were willing to undergo re-examination.ConclusionsRB using HFO and deep sedation, without mechanical ventilation or anesthesiologist support, was feasible across a heterogeneous, unselected cohort, with an acceptable complication profile and favorable patient-reported tolerability. These findings support further prospective, comparative evaluation of this approach, particularly in settings with limited anesthesiology support.